Switch theme
Sign up to access all valuation multiples
Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.
1973
18.7K+
LTM Revenue n/a
LTM EBITDA n/a
$788M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Rhoen Klinikum has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Rhoen Klinikum achieved revenue of $1.7B and an EBITDA of $131M.
Rhoen Klinikum expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Rhoen Klinikum valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.6B | $1.7B | XXX | XXX | XXX |
| Gross Profit | $45.5M | -$7.6M | XXX | XXX | XXX |
| Gross Margin | 3% | 0% | XXX | XXX | XXX |
| EBITDA | $126M | $131M | XXX | XXX | XXX |
| EBITDA Margin | 8% | 8% | XXX | XXX | XXX |
| Net Profit | $27.0M | $41.6M | XXX | XXX | XXX |
| Net Margin | 2% | 2% | XXX | XXX | XXX |
| Net Debt | $77.7M | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Rhoen Klinikum's stock price is EUR 15 (or $16).
Rhoen Klinikum has current market cap of EUR 1.0B (or $1.1B), and EV of EUR 734M (or $788M).
See Rhoen Klinikum trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $788M | $1.1B | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Rhoen Klinikum has market cap of $1.1B and EV of $788M.
Rhoen Klinikum's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Rhoen Klinikum's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Rhoen Klinikum and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $788M | XXX | XXX | XXX |
| EV/Revenue | 0.5x | XXX | XXX | XXX |
| EV/EBITDA | 6.0x | XXX | XXX | XXX |
| P/E | 23.3x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 12.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpRhoen Klinikum's NTM/LTM revenue growth is n/a
Rhoen Klinikum's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $8K for the same period.
Over next 12 months, Rhoen Klinikum's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Rhoen Klinikum's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Rhoen Klinikum and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $8K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 8% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Rhoen Klinikum acquired XXX companies to date.
Last acquisition by Rhoen Klinikum was XXXXXXXX, XXXXX XXXXX XXXXXX . Rhoen Klinikum acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Rhoen Klinikum founded? | Rhoen Klinikum was founded in 1973. |
| Where is Rhoen Klinikum headquartered? | Rhoen Klinikum is headquartered in Germany. |
| How many employees does Rhoen Klinikum have? | As of today, Rhoen Klinikum has 18.7K+ employees. |
| Is Rhoen Klinikum publicy listed? | Yes, Rhoen Klinikum is a public company listed on ETR. |
| What is the stock symbol of Rhoen Klinikum? | Rhoen Klinikum trades under RHK ticker. |
| When did Rhoen Klinikum go public? | Rhoen Klinikum went public in 1989. |
| Who are competitors of Rhoen Klinikum? | Similar companies to Rhoen Klinikum include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Rhoen Klinikum? | Rhoen Klinikum's current market cap is $1.1B |
| What is the current revenue growth of Rhoen Klinikum? | Rhoen Klinikum revenue growth between 2023 and 2024 was 9%. |
| Is Rhoen Klinikum profitable? | Yes, Rhoen Klinikum is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
